Veterinary Sutures - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the veterinary sutures market size was valued at USD 527.60 million in 2025 and is estimated to grow from USD 567.10 million in 2026 to reach USD 818.40 million by 2031, at a CAGR of 7.66% during the forecast period (2026-2031).

This report is Segmented by Suture Type (Absorbable, Non-Absorbable), Structure (Monofilament, Multifilament), Animal Type (Companion Animals, Livestock), End User (Veterinary Hospitals, Clinics, Ambulatory Centers, and More), Application (Soft Tissue, Orthopedic, and More), and Geography (North America, Europe, Asia-Pacific, MEA, South America). Market Forecasts are Provided in Terms of Value (USD).

Global Veterinary Sutures Market Trends and Insights

High Surgical Volumes in Companion Animals Drive Baseline Demand

Shelters admitted 2.8 million animals in the United States during the first half of 2025, and adoption rates climbed to 76%, seeding future elective surgeries that consume large suture quantities . High-quality high-volume spay-neuter (HQHVSN) clinics now complete 25-60 procedures daily, standardizing barbed absorbable sutures to maximize throughput. Lower procedure costs from these efficiencies broaden access for cost-sensitive pet owners and municipalities, stabilizing demand even in downturns. Rising diagnostic-imaging use is pushing tumor resections higher, layering additional volume. Together, shelter sterilization and owner-funded elective work form a resilient dual-engine that underpins the veterinary sutures market.

Pet Insurance Expansion Unlocks Advanced Procedures

North American pet-insurance premiums grew 20.8% in 2024 to USD 5.15 billion, lifting insured pets to 6.4 million and reducing out-of-pocket hurdles for advanced surgeries . Policies now routinely cover orthopedic repairs and complex oncologic work, driving uptake of absorbable and barbed lines that reduce anesthesia episodes. European penetration already exceeds 25% in the United Kingdom and Scandinavia, and pilot products in urban China and India are replicating this model. As insurance spreads, case-mix shifts to higher-acuity interventions that need more and more sophisticated closure materials, lifting both volume and average selling price. Insurers' reimbursement guidelines also validate premium products, reinforcing their position in the veterinary sutures market.

Tissue Adhesives and Staples Erode Share in Select Applications

Cyanoacrylate glues and skin staples close low-tension wounds in seconds, saving surgeon time and allowing technicians to handle routine closures under supervision. HQHVSN clinics adopt them aggressively because minutes shaved per case multiply across dozens of daily procedures. Nonetheless, adhesives cost more per use when waste from partially used tubes is factored in, and staples require a removal visit unless absorbable variants are chosen, narrowing their appeal. The substitution risk is therefore confined to roughly 10-15% of the veterinary sutures market, mainly within commodity non-absorbable lines.

Other drivers and restraints analyzed in the detailed report include:

1. Absorbable Sutures Reduce Follow-Up Visits and Anesthesia Risk
2. Asia-Pacific Veterinary Infrastructure Expansion Creates Long-Term Growth
3. Private-Label and Regional Manufacturers Intensify Price Pressure

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Absorbable products captured 56.30% of the veterinary sutures market share in 2025 and are forecast to grow with 8.12% CAGR. Hospitals prefer polyglycolic-acid and polydioxanone lines for soft-tissue closures because they negate removal visits, reduce anesthesia risk, and satisfy owner convenience. The veterinary sutures market size tied to absorbables is therefore rising faster than overall revenue growth, even in price-sensitive regions where follow-up logistics are difficult.

Barbed absorbable variants compound the speed advantage by eliminating knots, and early adoption in HQHVSN programs signals mainstream diffusion. Non-absorbables keep niche roles in tendon repairs and large-animal external skin closures where lasting tensile support is vital, yet their share is eroding as polymer science boosts absorbable strength. Regulatory scrutiny from FDA-CVM on hydrolysis profiles sets a quality baseline that discourages low-grade imports, maintaining brand loyalty where surgical risk is highest.

Monofilament lines held 61.67% of market revenue in 2025, and are expected to grow at 8.21% CAGR by 2031. Reduced tissue drag shortens operating time, and lower bacterial adherence aligns with antimicrobial-stewardship goals. Consequently, the value slice of the veterinary sutures market size earned by monofilament is growing faster than braided alternatives.

Barbed monofilament adds another layer of utility, merging infection control with time savings. Braided sutures still dominate cardiovascular and ophthalmic procedures where pliability overrides infection concerns. Manufacturers counter monofilament gains by adding antibacterial coatings to braided lines, but structural disadvantages remain. As clinics measure post-operative complication rates more rigorously, surgeons default to monofilament for contaminated fields, reinforcing the shift.

Geography Analysis

North America accounted for 35.78% of the veterinary sutures market in 2025, underpinned by more than 30,000 U.S. practices and 6.4 million insured pets that authorize elective interventions. Workforce shortages temper growth, yet HQHVSN programs performing up to 60 sterilizations daily keep baseline volumes healthy. FDA-CVM regulations on biocompatibility maintain a quality floor that favors established suppliers.

Europe is projected to post an 8.03% CAGR through 2031, the fastest among all regions. AniCura's 400-clinic network centralizes purchasing and accelerates adoption of triclosan-coated lines under uniform protocols. EMA device-approval harmonization lowers launch hurdles, and pet-insurance penetration above 25% in the United Kingdom sustains demand for premium absorbables. Eastern Europe emerges as a price-competitive manufacturing base for private-label sutures, while Scandinavian countries pilot next-gen antimicrobial coatings.

Asia-Pacific trails in market share but leads in incremental volume, driven by China's USD 39.8 billion pet economy and rapid hospital build-outs. Japan provides a mature template for specialty practice, and Indian chains open flagship hospitals in metros, widening access. Regional makers like Genia Group and Orion Sutures win on price, yet rising quality expectations open lanes for branded coated and barbed imports. Middle East & Africa and South America remain small but rising as disposable incomes widen surgical access, with Brazil's large dog population anchoring Latin American demand.

1. Arthrex Vet Systems
2. Assut Europe / AIP Medical
3. B. Braun
4. Corza Medical, Inc.
5. Covetrus Brand Sutures
6. DemeTECH
7. Dolphin Sutures
8. Genia Group
9. Johnson & Johnson
10. KATSAN
11. KRUUSE
12. Lotus Surgicals
13. Medtronic
14. Orion Sutures
15. Peters Surgical
16. Pivetal
17. ProNorth Medical
18. Riverpoint Medical
19. Securos Surgical
20. SMI (Sutures.be)
21. VeterSut
22. Vitrex Medical A/S

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support